CLINICAL_TRIALS
trial_result
· 2022-09-01
Clinical Trial Update: Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer [Phase 2, Phase 3]
Summary
A Phase 2/3 trial evaluated haloperidol with or without chlorpromazine for delirium in patients with advanced, metastatic, or recurrent cancer; results were pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Neoplasm, Delirium | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-09-01